Viridian Therapeutics, Inc./DE Share-based Payment Arrangement, Expense
Viridian Therapeutics, Inc./DE (VRDN) reported Share-based Payment Arrangement, Expense of $16.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for the quarter ending 2026-06-30 was $16.98M, a 56.62% increase year-over-year.
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for the quarter ending 2026-03-31 was $13.39M, a 31.02% increase year-over-year.
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for the quarter ending 2025-12-31 was $11.99M, a 33.58% increase year-over-year.
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for the quarter ending 2025-09-30 was $11.25M, a 29.01% increase year-over-year.
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for fiscal 2025 was $44.30M, a 5.11% increase from fiscal 2024.
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for fiscal 2024 was $42.15M, a 37.25% decline from fiscal 2023.
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for fiscal 2023 was $67.17M, a 239.85% increase from fiscal 2022.
- Viridian Therapeutics, Inc./DE share-based payment arrangement, expense for fiscal 2022 was $19.77M, a 36.64% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.98M 10-Q · filed 2026-08-06 | $30.37M 10-Q · filed 2026-08-06 | $42.36M derived: sum of 3 quarters · filed 2026-08-06 | $53.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $13.39M 10-Q · filed 2026-05-05 | $25.38M derived: sum of 2 quarters · filed 2026-05-05 | $36.63M derived: sum of 3 quarters · filed 2026-05-05 | $47.47M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $11.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.24M derived: sum of 2 quarters · filed 2026-02-26 | $34.08M derived: sum of 3 quarters · filed 2026-08-06 | $44.30M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $11.25M 10-Q · filed 2025-11-05 | $22.09M derived: sum of 2 quarters · filed 2026-08-06 | $32.31M 10-Q · filed 2025-11-05 | $41.29M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $10.84M 10-Q · filed 2026-08-06 | $21.06M 10-Q · filed 2026-08-06 | $30.04M derived: sum of 3 quarters · filed 2026-08-06 | $38.76M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $10.22M 10-Q · filed 2026-05-05 | $19.20M derived: sum of 2 quarters · filed 2026-05-05 | $27.91M derived: sum of 3 quarters · filed 2026-05-05 | $39.68M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $8.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.70M derived: sum of 2 quarters · filed 2026-02-26 | $29.46M derived: sum of 3 quarters · filed 2026-02-26 | $42.15M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $8.72M 10-Q · filed 2025-11-05 | $20.49M derived: sum of 2 quarters · filed 2025-11-05 | $33.17M 10-Q · filed 2025-11-05 | $59.22M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $11.77M 10-Q · filed 2025-08-06 | $24.45M 10-Q · filed 2025-08-06 | $50.50M derived: sum of 3 quarters · filed 2026-02-26 | $64.11M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $12.69M 10-Q · filed 2025-05-06 | $38.74M derived: sum of 2 quarters · filed 2026-02-26 | $52.34M derived: sum of 3 quarters · filed 2026-02-26 | $64.64M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $26.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $39.65M derived: sum of 2 quarters · filed 2026-02-26 | $51.96M derived: sum of 3 quarters · filed 2026-02-26 | $67.17M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $13.61M 10-Q · filed 2024-11-12 | $25.91M derived: sum of 2 quarters · filed 2024-11-12 | $41.12M 10-Q · filed 2024-11-12 | $46.40M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $12.30M 10-Q · filed 2024-08-08 | $27.52M 10-Q · filed 2024-08-08 | $32.80M derived: sum of 3 quarters · filed 2025-03-03 | $37.74M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $15.22M 10-Q · filed 2024-05-08 | $20.49M derived: sum of 2 quarters · filed 2025-03-03 | $25.44M derived: sum of 3 quarters · filed 2025-03-03 | $30.32M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $10.22M derived: sum of 2 quarters · filed 2025-03-03 | $15.11M derived: sum of 3 quarters · filed 2025-03-03 | $19.77M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $4.94M 10-Q · filed 2023-11-13 | $9.83M derived: sum of 2 quarters · filed 2023-11-13 | $14.49M 10-Q · filed 2023-11-13 | $17.98M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $4.88M 10-Q · filed 2023-08-08 | $9.54M 10-Q · filed 2023-08-08 | $13.04M derived: sum of 3 quarters · filed 2024-02-27 | $17.02M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | $4.66M 10-Q · filed 2023-05-10 | $8.15M derived: sum of 2 quarters · filed 2024-02-27 | $12.13M derived: sum of 3 quarters · filed 2024-02-27 | $15.95M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $7.47M derived: sum of 2 quarters · filed 2024-02-27 | $11.29M derived: sum of 3 quarters · filed 2024-02-27 | $14.46M 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $3.98M 10-Q · filed 2022-11-14 | $7.80M derived: sum of 2 quarters · filed 2022-11-14 | $10.97M 10-Q · filed 2022-11-14 | $12.72M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $3.82M 10-Q · filed 2022-08-15 | $6.99M 10-Q · filed 2022-08-15 | $8.73M derived: sum of 3 quarters · filed 2022-08-15 | $9.35M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $3.17M 10-Q · filed 2022-05-13 | $4.92M derived: sum of 2 quarters · filed 2022-05-13 | $5.53M derived: sum of 3 quarters · filed 2022-05-13 | $6.16M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.36M derived: sum of 2 quarters · filed 2022-03-11 | $2.98M derived: sum of 3 quarters · filed 2022-03-11 | $3.65M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $615.00K 10-Q · filed 2021-11-05 | $1.24M derived: sum of 2 quarters · filed 2021-11-05 | $1.90M 10-Q · filed 2021-11-05 | $2.90M derived: sum of 4 quarters · filed 2021-11-05 | ||||
| 2020-06-30 | $623.00K 10-Q · filed 2021-08-12 | $1.29M 10-Q · filed 2021-08-12 | $2.29M derived: sum of 3 quarters · filed 2021-08-12 | $3.16M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $664.00K 10-Q · filed 2021-05-07 | $1.67M derived: sum of 2 quarters · filed 2021-05-07 | $2.54M derived: sum of 3 quarters · filed 2021-05-07 | $3.62M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $1.88M derived: sum of 2 quarters · filed 2021-03-26 | $2.95M derived: sum of 3 quarters · filed 2021-03-26 | $3.97M 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $874.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.95M derived: sum of 2 quarters · filed 2020-11-12 | $2.97M 10-Q · filed 2020-11-12 | $3.90M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $2.09M 10-Q · filed 2020-08-05 | $3.03M derived: sum of 3 quarters · filed 2020-08-05 | $4.00M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $1.02M 10-Q · filed 2020-05-08 | $1.96M derived: sum of 2 quarters · filed 2020-05-08 | $2.92M derived: sum of 3 quarters · filed 2020-05-08 | $3.91M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $937.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.91M derived: sum of 2 quarters · filed 2020-03-13 | $2.89M derived: sum of 3 quarters · filed 2020-03-13 | $3.68M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $968.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.95M derived: sum of 2 quarters · filed 2019-11-08 | $2.74M 10-Q · filed 2019-11-08 | $3.46M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $984.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.77M 10-Q · filed 2019-08-08 | $2.49M derived: sum of 3 quarters · filed 2019-08-08 | $3.17M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $790.00K 10-Q · filed 2019-05-09 | $1.51M derived: sum of 2 quarters · filed 2019-05-09 | $2.19M derived: sum of 3 quarters · filed 2019-05-09 | $2.78M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $716.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.40M derived: sum of 2 quarters · filed 2019-03-14 | $1.99M derived: sum of 3 quarters · filed 2019-03-14 | $2.41M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $679.00K 10-Q · filed 2017-11-09 | $1.27M derived: sum of 2 quarters · filed 2017-11-09 | $1.69M 10-Q · filed 2018-11-07 | $1.76M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $595.00K 10-Q · filed 2017-08-11 | $1.01M 10-Q · filed 2018-08-08 | $1.08M derived: sum of 3 quarters · filed 2018-05-09 | $1.13M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | $419.00K 10-Q · filed 2018-05-09 | $268.00K 10-Q · filed 2017-05-11 | $488.00K derived: sum of 2 quarters · filed 2018-05-09 | $533.00K derived: sum of 3 quarters · filed 2018-05-09 | $575.00K derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $114.00K derived: sum of 2 quarters · filed 2018-03-15 | $156.00K derived: sum of 3 quarters · filed 2018-03-15 | $198.00K 10-K · filed 2018-03-15 | $2.11M 10-K · filed 2017-03-24 | |||
| 2016-09-30 | $45.00K 10-Q · filed 2017-11-09 | $93.00K 10-Q · filed 2016-10-26 | $87.00K derived: sum of 2 quarters · filed 2017-11-09 | $129.00K 10-Q · filed 2017-11-09 | $1.44M 10-Q · filed 2016-10-26 | $882.00K derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $42.00K 10-Q · filed 2017-08-11 | $635.00K 10-Q · filed 2016-08-15 | $84.00K 10-Q · filed 2017-08-11 | $1.35M 10-Q · filed 2016-08-15 | $837.00K derived: sum of 3 quarters · filed 2017-08-11 | $1.68M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | $38.00K 10-Q · filed 2017-05-11 | $713.00K 10-Q · filed 2016-05-16 | $795.00K derived: sum of 2 quarters · filed 2017-05-11 | $1.63M derived: sum of 3 quarters · filed 2017-05-11 | $2.35M derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | $757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $1.59M derived: sum of 2 quarters · filed 2017-03-24 | $2.31M derived: sum of 3 quarters · filed 2017-03-24 | $3.02M 10-K · filed 2017-03-24 | ||||
| 2015-09-30 | $838.00K 10-Q · filed 2016-10-26 | $1.55M derived: sum of 2 quarters · filed 2016-10-26 | $2.26M 10-Q · filed 2016-10-26 | $2.98M derived: sum of 4 quarters · filed 2016-10-26 | ||||
| 2015-06-30 | $712.00K 10-Q · filed 2016-08-15 | $1.42M 10-Q · filed 2016-08-15 | $2.14M derived: sum of 3 quarters · filed 2016-08-15 | $2.84M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $708.00K 10-Q · filed 2016-05-16 | $1.43M derived: sum of 2 quarters · filed 2016-05-16 | $2.13M derived: sum of 3 quarters · filed 2016-05-16 | $5.01M derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $720.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $1.42M derived: sum of 2 quarters · filed 2016-03-21 | $4.30M derived: sum of 3 quarters · filed 2016-03-21 | $4.30M 10-K · filed 2016-03-21 | ||||
| 2014-09-30 | $703.00K 10-Q · filed 2015-11-13 | $3.58M derived: sum of 2 quarters · filed 2015-11-13 | $3.58M 10-Q · filed 2015-11-13 | |||||
| 2014-06-30 | $2.88M 10-Q · filed 2015-08-14 | $2.88M 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |